Please login to Zacks.com or register to post a comment.
| No Recent Quote currently available |
|
My Portfolio Tracker One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today. |
Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.
Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.
Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.
My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.
| Company Name | Symbol | %Change |
|---|---|---|
| ALLIANCE FIB | AFOP | 14.22% |
| TRI TECH HOL | TRIT | 10.00% |
| A M R CP | AAMRQ | 9.04% |
| JAZZ PHARMAC | JAZZ | 5.48% |
| SANTARUS INC | SNTS | 5.02% |
Please login to Zacks.com or register to post a comment.
Resources
Client Support
Zacks Research is Reported On:
Zacks Investment Research
is an A+ Rated BBB
Accredited Business.
Copyright 2013 Zacks Investment Research
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1986 it has nearly tripled the S&P 500 with an average gain of +26% per year. These returns cover a period from 1986-2011 and were examined and attested by Baker Tilly, an independent accounting firm.
Visit performance for information about the performance numbers displayed above.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This page is temporarily not available. Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext. 9339.
Kraton Performance Polymers, Inc. ( KRA - Snapshot Report ) will feature its Cariflex polyisoprene products at MEDTEC Europe, scheduled to be held in Stuttgart, Germany, from Feb 26–28. These products are used in high performance medical applications, where they act as a substitute for natural rubber.
The company, at MEDTEC Europe, will make a technical presentation titled "Super clean polyisoprene polymer and latex for high performance medical devices" on Feb 27. The presentation will focus on how Cariflex polyisoprene products protect health care professionals and consumers from infection, contamination and allergic reactions. Detailed, comparative performance data in specific applications such as medical stoppers and surgical gloves will be provided during the presentation.
Product experts, at the company’s booth at MEDTEC Europe, will demonstrate how Cariflex polyisoprene products effectively serves medical devices markets including catheters, tube connectors, needle shields, probe covers, and cohesive bandages and are suitable for applications that require the high tensile strength and tear resistance of natural rubber.
Kraton is a leading global producer of engineered polymers used to enhance the performance of products. The company also invented styrenic block copolymer (SBC) chemistry and its portfolio also consists of value-enhancing polymers that are used in a wide variety of applications.
Kraton reported its third-quarter 2012 results in Oct 2012. The company logged a net loss of 48 cents per share compared with a profit of $1.33 per share in the year-ago quarter. The results include impairment charges and the impact related to changes in the company’s valuation allowance. Revenues decreased 14.8% year over year to $342.6 million in the quarter.
Kraton, which currently retains a short-term Zacks Rank #3 (Hold), will report its fourth quarter results on Feb 27.
Other companies in the specialty chemical industry with favorable Zacks Rank are Landec Corp. ( LNDC - Snapshot Report ) , A. Schulman, Inc. ( SHLM - Snapshot Report ) and Westlake Chemical Corp. ( WLK - Snapshot Report ) . While Landec holds a Zacks Rank #1 (Strong Buy), both A. Schulman and Westlake retain a Zacks Rank #2 (Buy).
Read the full reports :
Snapshot Report on WLK
Snapshot Report on KRA
Snapshot Report on LNDC
Snapshot Report on SHLM